Akebia Therapeutics has successfully completed a Phase I trial of its anemia drug in healthy human volunteers, the company announced.
The drug, a pill known as AKB-6548, was shown to successfully and safely produce the erythropoietin (EPO) hormone that promotes the growth of red blood cells in bone marrow.
No comments:
Post a Comment